Molecular Biomarkers & Diagnosis

Hala FM Kamel

Publications

• Review Article
  Conventional and Promising Biomarkers for Prostate Cancer their Clinical Implication and Prospective Role
  Author(s): Hala FM Kamel and Anmar M NassirHala FM Kamel and Anmar M Nassir
  
  Prostate cancer (PCa) is one of the most common cancer in men and most common causes of male cancerrelated deaths. Over many years, biomarkers have been extensively studied for screening, diagnosis, prediction of (PCa) behavior and outcome and for assigning the patients during treatments. Molecular biomarkers could also help scientists to attain better understanding for the molecular basis of the disease and prediction of the patient response to therapies. Early detection of PCa was made possible about 30 years ago by the introduction of prostate specific antigen (PSA) in the clinical practice. However, PCa screening remains controversial, because of the risk of over diagnosis and/or over treatment and the inability to detect a significant proportion of advanced tumors. Several novel biomarkers have shown promises in preliminary studies. This review will f.. Read More»
  DOI: 10.4172/2155-9929.1000262

  Abstract PDF